Search Results for "claims"

• Cook M , Beachler DC , Parlett LE , Cochetti PT , Finkle WD , Lanes S . Abstract 5050: testosterone supplementation in relation to prostate cancer in a us commercial insurance claims database . Poster presented at: 2019 American Association for Cancer Research (AACR) Annual Meeting; March 29 - April 03, 2019; Atlanta, GA, US . https://aacrjournals.org/cancerres/article/79/13_Supplement/5050/636990/Abstract-5050-Testosterone-supplementation-in . doi: 10.1158/1538-7445.AM2019-5050 .
• Maro JC , Wiley M , Cole DV et al . High throughput signal identification of drug use in pregnancy for detection of adverse infant outcomes . Podium presented at: 2024 International Society for Pharmacoepidemiology Annual Meeting; August 24 - August 28, 2024; Berlin, DE .
• Parlett LE , Ball K , Pipkin CA , Kappelman MD , Bocage C , Long MD . Compared to thiopurines and tumor necrosis factor inhibitors novel biologics are associated with reduced risk of non-melanoma skin cancer among patients with inflammatory bowel disease . Poster presented at: 2024 International Society for Pharmacoepidemiology Annual Meeting; August 24 - August 28, 2024; Berlin, DE .
• Hoffman SR , Parlett LE , Lanes S . Characterizing patients with postural orthostatic tachycardia syndrome (POTS) in claims data after the introduction of a specific diagnosis code . Poster presented at: 2024 International Society for Pharmacoepidemiology Annual Meeting; August 24 - August 28, 2024; Berlin, DE .
• Forshee R , Smith ER , Wan Z et al . Evaluation of febrile seizure risk following ancestral monovalent COVID-19 mrna vaccination among U.S. children aged 2-5 years . Podium presented at: 2024 International Society for Pharmacoepidemiology Annual Meeting; August 24 - August 28, 2024; Berlin, DE .
• Anthony MS , Djebarri L , Beachler DC et al . Risk of anaphylaxis among new users of glucagon-like peptide-1 receptor agonists (GLP-1 ras) . Poster presented at: 2023 American Diabetes Association Scientific Sessions; June 23 - June 26, 2023; San Diego, CA, US . https://diabetesjournals.org/diabetes/article/72/Supplement_1/846-P/150217/846-P-Risk-of-Anaphylaxis-among-New-Users-of . doi: 10.2337/db23-846-P .
• Rege S , Parlett LE , Neikirk AL et al . New diagnoses of juvenile idiopathic arthritis early in the COVID-19 pandemic analysis of a large United States commercial insurance database .J Clin Rheumatol. 2025; 31 (1) : 40-4 . doi: 10.1097/RHU.0000000000002154 .
• Clarke TC , Lloyd P , Jiao Y et al . Immunization information systems data supplementing health insurance claims for vaccine safety and effectiveness studies . Podium presented at: 2024 American Immunization Registry Association National Meeting; May 07 - May 09, 2024; Orlando, FL, US .
• Lewis JD , Brensinger CM , Parlett LE , Hurtado-Lorenzo A , Kappelman MD . Provider specialization in inflammatory bowel diseases: quality of care and outcomes .Clin Gastroenterol Hepatol. 2024; 22 (12) : 2475-86.e14 . doi: 10.1016/j.cgh.2024.05.024 .
• Singh S , Li X , Cocoros NM et al . High-risk medications in persons living with dementia: a randomized clinical trial .Jama Intern Med. 2024; 184 (12) : 1426-33 . doi: 10.1001/jamainternmed.2024.5632 .
• Long MD , Parlett LE , Lewis JD et al . Corticosteroids but not anti-TNF are associated with increased COVID-19 complications in patients with inflammatory bowel disease .Inflamm Bowel Dis. 2024; 30 (8) : 1345–52 . doi: 10.1093/ibd/izad176 .
• Adimadhyam S , Lewis JD , Simon AL et al . Real-world evidence comparing tofacitinib and vedolizumab in anti-TNF-experienced patients with ulcerative colitis .Inflamm Bowel Dis. 2024; 30 (4) : 554-62 . doi: 10.1093/ibd/izad115 .
• Anthony MS , Aroda VR , Parlett LE et al . Risk of anaphylaxis among new users of GLP-1 receptor agonists: a cohort study .Diabetes Care. 2024; 47 (4) : 712-9 . doi: 10.2337/dc23-1911 .
• Singh S , Cocoros NM , Li X et al . Developing a program to educate and sensitize caregivers to reduce the inappropriate prescription burden in the elderly with alzheimer's disease (D-PRESCRIBE-AD): trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial .Plos One. 2024; 19 (2) : e0297562 . doi: 10.1371/journal.pone.0297562 .
• Forrest CB , Chen CP , Perrin EM et al . Pediatric medical subspecialist use in outpatient settings .Jama Netw Open. 2024; 7 (1) : e2350379 . doi: 10.1001/jamanetworkopen.2023.50379 .
• Dawwas GK , Weiss A , Constant BD et al . Development and validation of claims-based definitions to identify incident and prevalent inflammatory bowel disease in administrative healthcare databases .Inflamm Bowel Dis. 2023; 29 (12) : 1993-6 . doi: 10.1093/ibd/izad053 .
• Horton DB , Yang Y , Neikirk AL et al . Impact of the COVID-19 pandemic on the management of juvenile idiopathic arthritis: analysis of United States commercial insurance data .J Clin Rheumatol. 2023; 29 (8) : 388-95 . doi: 10.1097/RHU.0000000000002035 .
• Lewis JD , Parlett LE , Jonsson Funk ML et al . Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States .Gastroenterology. 2023; 165 (5) : 1197-1205.e2 . doi: 10.1053/j.gastro.2023.07.003 .
• Cocoros NM , Gurwitz J , Cziraky MJ et al . Pragmatic guidance for embedding pragmatic clinical trials in health plans: large simple trials aren't so simple .Clin Trials. 2023; 20 (4) : 416-24 . doi: 10.1177/17407745231160459 .
• Kappelman MD , Adimadhyam S , Hou L et al . Real-world evidence comparing vedolizumab and ustekinumab in antitumor necrosis factor-experienced patients with crohn's disease .Am J Gastroenterol. 2023; 118 (4) : 674-84 . doi: 10.14309/ajg.0000000000002068 .
• Horton DB , Neikirk AL , Yang Y et al . Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States .Respir Res. 2023; 24 (1) : 72 . doi: 10.1186/s12931-023-02377-7 .
• Parlett LE , Ma Q , Shi Q et al . Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus .Diabetol Metab Syndr. 2021; 13 (1) : 47 . doi: 10.1186/s13098-021-00665-0 .
• Cook M , Beachler DC , Parlett LE et al . Testosterone therapy in relation to prostate cancer in a U.S. commercial insurance claims database .Cancer Epidemiol Biomarkers Prev. 2020; 29 (1) : 236-45 . doi: 10.1158/1055-9965.EPI-19-0619 .
• Parlett LE , Agiro A , Brown S et al . Drivers of hospital length of stay in medicaid and commercially insured mother-infant pairs with a diagnosis of neonatal abstinence syndrome .Med Care. 2019; 57 (12) : 977-83 . doi: 10.1097/MLR.0000000000001199 .
• Parlett LE , Beachler DC , Lanes S , Hoover R , Cook M . Validation of an algorithm for claims-based incidence of prostate cancer .Epidemiology. 2019; 30 (3) : 466-71 . doi: 10.1097/EDE.0000000000001007 .
• Xie Y , Parlett LE , Gordon A , Sylwestrzak G , Barron J . Characteristics of early sacubitril/valsartan users in a managed care population with heart failure to inform future outcomes studies . Poster presented at: 2017 International Society of Pharmacoeconomics and Outcomes Research Annual International Meeting; May 20 - May 24, 2017; Boston, MA, US .
• Chen X , Fishman E , Franck L , Parlett LE , Sylwestrzak M , Cahow E . Understanding medicare advantage members’ health plan satisfaction using high dimensional administrative data . Poster presented at: 2018 AcademyHealth Annual Research Meeting; June 04 - June 26, 2018; Seattle, WA, US .
• Kawai AT , Andrade SE , Zichittella L et al . Developing the infrastructure to conduct surveillance of birth outcomes following maternal vaccination: a project using influenza vaccines and birth outcomes as a use case . Published March 28, 2018. https://www.sentinelinitiative.org/sites/default/files/vaccines-blood-biologics/assessments/PRISM_Influenza_Vaccines_and_Birth_Outcomes_Final_Report.pdf .
• Beachler DC , Parlett LE , Lanes S , Hoover R , Cook M . Testosterone supplementation in relation to prostate cancer in a us commercially-insured claims database . Podium presented at: 2018 International Society for Pharmacoepidemiology International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22 - August 26, 2018; Praha 4-Nusle, CZ .